These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7221503)

  • 41. Above-knee femoropopliteal reconstruction with polytetrafluoroethylene: a good alternative to saphenous vein bypass.
    Laurendeau F; Lassonde J
    Can J Surg; 1989 Jan; 32(1):48-50. PubMed ID: 2910380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Femoropopliteal venous bypass in distal duplication of the great saphenous vein with bridge veins. Case report].
    Fankhauser G; Froelicher P; Maurer W
    Helv Chir Acta; 1991 Jul; 58(1-2):173-6. PubMed ID: 1938441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature.
    Klinkert P; Post PN; Breslau PJ; van Bockel JH
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):357-62. PubMed ID: 15015183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atherosclerotic aneurysm formation in a femoropopliteal saphenous vein graft.
    Cloud W; Handte G; Kron IL
    South Med J; 1984 May; 77(5):652-7. PubMed ID: 6719169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative evaluation of prosthetic, reversed, and in situ vein bypass grafts in distal popliteal and tibial-peroneal revascularization. Veterans Administration Cooperative Study Group 141.
    Arch Surg; 1988 Apr; 123(4):434-8. PubMed ID: 3348735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The upper arm basilic-cephalic loop for distal bypass grafting: technical considerations and follow-up.
    Hölzenbein TJ; Pomposelli FB; Miller A; Gibbons GW; Campbell DR; Freeman DV; LoGerfo FW
    J Vasc Surg; 1995 Apr; 21(4):586-92; discussion 592-4. PubMed ID: 7707564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autogenous reversed vein bypass for lower extremity ischemia in patients with absent or inadequate greater saphenous vein.
    Taylor LM; Edwards JM; Brant B; Phinney ES; Porter JM
    Am J Surg; 1987 May; 153(5):505-10. PubMed ID: 3578671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An 11-year experience with deep leg veins as femoropopliteal bypass grafts.
    Schulman ML; Badhey MR; Yatco R; Pillari G
    Arch Surg; 1986 Sep; 121(9):1010-5. PubMed ID: 3741095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial.
    Klinkert P; Schepers A; Burger DH; van Bockel JH; Breslau PJ
    J Vasc Surg; 2003 Jan; 37(1):149-55. PubMed ID: 12514593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iatrogenic entrapment of femoropopliteal saphenous vein bypass grafts by the gastrocnemius muscle.
    Brener BJ; Alpert J; Brief DK; Parsonnet V
    Surgery; 1975 Nov; 78(5):668-74. PubMed ID: 1188609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autologous saphenous vein popliteal-tibial artery bypass for limb-threatening ischemia: a reassessment.
    Ballard JL; Killeen JD; Bunt TJ; Malone JM
    Am J Surg; 1995 Sep; 170(3):251-5. PubMed ID: 7661292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A saphenous alternative: preferential use of superficial femoral and popliteal veins as femoropopliteal bypass grafts.
    Schulman ML; Badhey MR; Yatco R; Pillari G
    Am J Surg; 1986 Aug; 152(2):231-7. PubMed ID: 3740362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An argument against all-autogenous tissue for vascular bypasses below the inguinal ligament.
    Moore WS; Quiñones-Baldrich WJ
    Adv Surg; 1991; 24():91-101. PubMed ID: 1996531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endoscopic versus open great saphenous vein harvesting for femoral to popliteal artery bypass.
    Mirza AK; Stauffer K; Fleming MD; De Martino R; Oderich G; Kalra M; Gloviczki P; Bower T
    J Vasc Surg; 2018 Apr; 67(4):1199-1206. PubMed ID: 29102747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing patency of the autogenous vein-femoropopliteal bypass graft: an analysis of 74 cases.
    Koontz TJ; Stansel HC
    Surgery; 1972 May; 71(5):753-9. PubMed ID: 5026965
    [No Abstract]   [Full Text] [Related]  

  • 56. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts.
    Buckley CJ; Abernathy S; Lee SD; Arko FR; Patterson DE; Manning LG
    J Vasc Surg; 2000 Oct; 32(4):731-8. PubMed ID: 11013037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long term results of autogenous vein bypass grafts in femoropopliteal arterial occlusion.
    Grimley RP; Obeid ML; Ashton F; Slaney G
    Br J Surg; 1979 Oct; 66(10):723-6. PubMed ID: 509049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness.
    Szilagyi DE; Hageman JH; Smith RF; Elliott JP; Brown F; Dietz P
    Surgery; 1979 Dec; 86(6):836-51. PubMed ID: 515951
    [No Abstract]   [Full Text] [Related]  

  • 59. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis.
    Kretschmer G; Herbst F; Prager M; Sautner T; Wenzl E; Berlakovich GA; Zekert F; Marosi L; Schemper M
    Arch Surg; 1992 Sep; 127(9):1112-5. PubMed ID: 1514915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infrainguinal arterial reconstruction with nonreversed greater saphenous vein.
    Belkin M; Knox J; Donaldson MC; Mannick JA; Whittemore AD
    J Vasc Surg; 1996 Dec; 24(6):957-62. PubMed ID: 8976349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.